| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4B | $5.0B | $4.6B | $5.8B | $5.6B | $1.3B | $1.2B | $1.1B |
| Cost of Revenue | $2.8B | $2.6B | $2.5B | $3.2B | $3.0B | $2.4B | $2.4B | $2.2B |
| Gross Profit | $2.6B | $2.4B | $2.1B | $2.6B | $2.6B | $0.6B | $0.5B | $0.5B |
| R&D Expense | $0.6B | $0.6B | $0.5B | $0.6B | $0.6B | $0.5B | $0.4B | $0.4B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.7B | $0.5B | $0.5B | $1.0B | $0.7B | $0.7B | $0.6B |
| Net Income | $0.4B | $0.5B | $0.3B | $0.5B | $0.8B | $0.2B | $0.2B | $0.4B |
| EPS (Basic) | $8.24 | $10.25 | $5.75 | $8.86 | $15.66 | $3.73 | $3.13 | $2.14 |
| EPS (Diluted) | $8.18 | $10.18 | $5.72 | $8.80 | $15.52 | $3.70 | $3.10 | $2.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.5B | $8.0B | $7.3B | $7.5B | $6.2B | $5.4B | $4.7B | $4.3B |
| Current Assets | $1.8B | $2.4B | $1.7B | $1.9B | $1.7B | $1.3B | $1.2B | $1.2B |
| Cash & Equivalents | $0.1B | $0.9B | $0.1B | $0.1B | $0.3B | $0.2B | $0.0B | $0.0B |
| Total Liabilities | $4.9B | $4.4B | $4.3B | $4.8B | $3.2B | $3.2B | $2.9B | $3.0B |
| Current Liabilities | $1.9B | $1.7B | $1.6B | $2.3B | $1.8B | $1.9B | $1.4B | $1.3B |
| Stockholders' Equity | $3.6B | $3.6B | $3.0B | $2.7B | $3.0B | $2.1B | $1.8B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $1.0B | $-0.0B | $0.5B | $1.1B | $1.0B | $0.7B | $0.8B |
| Investing Cash Flow | $-1.5B | $-0.1B | $-0.1B | $-1.0B | $-0.5B | $-0.6B | $-0.3B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.2B | $-0.2B | $0.1B | $0.3B | $-0.4B | $-0.2B | $-0.4B | $-0.7B |